Call Us08045479576
Venlafaxine HCL

Venlafaxine HCL

25.00 - 50.00 INR

Product Details:

  • Molecular Weight 313.9 g/mol GSM (gm/2)
  • Storage Dry Place
  • Molecular Formula C17H28ClNO2
  • Medicine Name Venlafaxine HCL
  • Type Pharmaceutical Intermediates
  • Grade Medicine Grade
  • Purity(%) 98%
  • Click to View more
X

Venlafaxine HCL Price And Quantity

  • 25 Kilograms
  • 25.00 - 50.00 INR

Venlafaxine HCL Product Specifications

  • Powder
  • Pharmaceutical Intermediates
  • Medicine Grade
  • 313.9 g/mol GSM (gm/2)
  • 98%
  • Venlafaxine HCL
  • Dry Place
  • C17H28ClNO2

Venlafaxine HCL Trade Information

  • Cash in Advance (CID) Cash Advance (CA)
  • 1000 Kilograms Per Day
  • 7 Days
  • Western Europe Australia South America Eastern Europe Middle East Central America Asia North America Africa

Product Description

It is an antidepressant of the serotonin-norepinephrine reuptake inhibitor. We are recognized amongst the leading organizations engaged in offering Venlafaxine HCL to our clients. To process this drug, we use optimum quality compounds, sourced from trusted vendors. It is prescribed for the treatment of clinical depression and anxiety disorders. Venlafaxine HCL is used to treat depression. It can improve your mood and energy level, and can help restore your interest in daily living. This drug works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Venlafaxine is used in the treatment of depression. Additionally, extended-release (long-acting) capsules of venlafaxine can be used to treat depression, social anxiety disorder, and panic disorder. SNRIs (selective serotonin and norepinephrine reuptake inhibitors) include venlafaxine. It increases serotonin and norepinephrine, two natural substances in the brain that contribute to mental stability.

In some cases, women who are taking medication for breast cancer or who have experienced menopause can use venlafaxine to treat hot flashes.

 Technical Specifications:

  • CAS ID: 93413-69-5
  • Molecular Formula: C17H27NO2
  • Molecular Weight: 313.9
  • Synonyms: Elafax ,D,L-Venlafaxine
  • Melting Point: 217 °C
  • Form : Powder
  • Color : White to off-white crystalline solid

 

How does it work:

SNRIs include Venlafaxine. Several neurotransmitters in the brain are increased and regulated by it. It is made up of norepinephrine, also known as noradrenaline, and serotonin. Venlafaxine inhibits serotonin reuptake at low doses. Postsynaptic receptors are stimulated by this action as there are more transmitters at the synapse as a result.

Applications Or where it is used:

Depression, anxiety, panic attacks, and social anxiety disorder (social phobia) are treated with venlafaxine. It may boost your mood and energy level while restoring your interest in living. Additionally, it may lessen anxiety, panic attacks, and fear. Aside from its prescribed uses, it is used to treat diabetic neuropathy, migraine, and hot flashes.

How to use:

You can take Venlafaxine by mouth as a tablet or a capsule with an extended-release formula. Venlafaxine tablets are typically taken two to three times daily with food. It is usually taken once per day in the morning or evening with food. Each day, take venlafaxine at around the same time. If you do not understand the directions on your prescription label, ask your doctor or pharmacist. Don't split, chew, or crush the extended-release capsule, nor place it in water. Swallow it whole. The extended-release capsule treats depression but cannot cure it. The full effects of this medication may take 6 to 8 weeks to be felt. Keep taking venlafaxine even if you are feeling well. Do not stop taking it without consulting your physician.

Side effects:

You should see a doctor if you experience these symptoms of an allergic reaction: hives, skin rash, difficulty breathing, swelling of the face, lips, tongue, or throat.

Be sure to tell your doctor or healthcare provider about any new or worsening symptoms, such as: mood changes, depression, anxiety, panic attacks, trouble sleeping, restlessness, hyperactivity, impulsiveness, thoughts of suicide or harming yourself.

If you are having blurred vision, eye pain or redness, seeing halos around lights; coughing, chest tightness, trouble breathing; or a seizure (convulsions), call your doctor immediately.

Warnings and precautions while using this product:

Venlafaxine should not be taken by people with uncontrolled narrow-angle glaucoma. First-time antidepressants can cause young people to contemplate suicide. Watch for changes in mood and symptoms. Identify and report any prior mentioned new or worsening symptoms to your doctor. You should not give this medicine to anyone under 18 without consulting your doctor. This medicine is not FDA-approved for children. 

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
+91
  • India (भारत)+91
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United States+1
  • China (中国)+86
  • Afghanistan (‫افغانستان‬‎)+93
  • Albania (Shqipëri)+355
  • Algeria (‫الجزائر‬‎)+213
  • American Samoa+1684
  • Andorra+376
  • Angola+244
  • Anguilla+1264
  • Antigua and Barbuda+1268
  • Argentina+54
  • Armenia (Հայաստան)+374
  • Aruba+297
  • Australia+61
  • Austria (Österreich)+43
  • Azerbaijan (Azərbaycan)+994
  • Bahamas+1242
  • Bahrain (‫البحرين‬‎)+973
  • Bangladesh (বাংলাদেশ)+880
  • Barbados+1246
  • Belarus (Беларусь)+375
  • Belgium (België)+32
  • Belize+501
  • Benin (Bénin)+229
  • Bermuda+1441
  • Bhutan (འབྲུག)+975
  • Bolivia+591
  • Bosnia and Herzegovina (Босна и Херцеговина)+387
  • Botswana+267
  • Brazil (Brasil)+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1284
  • Brunei+673
  • Bulgaria (България)+359
  • Burkina Faso+226
  • Burundi (Uburundi)+257
  • Cambodia (កម្ពុជា)+855
  • Cameroon (Cameroun)+237
  • Canada+1
  • Cape Verde (Kabu Verdi)+238
  • Caribbean Netherlands+599
  • Cayman Islands+1345
  • Central African Republic (République centrafricaine)+236
  • Chad (Tchad)+235
  • Chile+56
  • China (中国)+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros (‫جزر القمر‬‎)+269
  • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
  • Congo (Republic) (Congo-Brazzaville)+242
  • Cook Islands+682
  • Costa Rica+506
  • Côte d’Ivoire+225
  • Croatia (Hrvatska)+385
  • Cuba+53
  • Curaçao+599
  • Cyprus (Κύπρος)+357
  • Czech Republic (Česká republika)+420
  • Denmark (Danmark)+45
  • Djibouti+253
  • Dominica+1767
  • Dominican Republic (República Dominicana)+1
  • Ecuador+593
  • Egypt (‫مصر‬‎)+20
  • El Salvador+503
  • Equatorial Guinea (Guinea Ecuatorial)+240
  • Eritrea+291
  • Estonia (Eesti)+372
  • Ethiopia+251
  • Falkland Islands (Islas Malvinas)+500
  • Faroe Islands (Føroyar)+298
  • Fiji+679
  • Finland (Suomi)+358
  • France+33
  • French Guiana (Guyane française)+594
  • French Polynesia (Polynésie française)+689
  • Gabon+241
  • Gambia+220
  • Georgia (საქართველო)+995
  • Germany (Deutschland)+49
  • Ghana (Gaana)+233
  • Gibraltar+350
  • Greece (Ελλάδα)+30
  • Greenland (Kalaallit Nunaat)+299
  • Grenada+1473
  • Guadeloupe+590
  • Guam+1671
  • Guatemala+502
  • Guernsey+44
  • Guinea (Guinée)+224
  • Guinea-Bissau (Guiné Bissau)+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong (香港)+852
  • Hungary (Magyarország)+36
  • Iceland (Ísland)+354
  • India (भारत)+91
  • Indonesia+62
  • Iran (‫ایران‬‎)+98
  • Iraq (‫العراق‬‎)+964
  • Ireland+353
  • Isle of Man+44
  • Israel (‫ישראל‬‎)+972
  • Italy (Italia)+39
  • Jamaica+1876
  • Japan (日本)+81
  • Jersey+44
  • Jordan (‫الأردن‬‎)+962
  • Kazakhstan (Казахстан)+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait (‫الكويت‬‎)+965
  • Kyrgyzstan (Кыргызстан)+996
  • Laos (ລາວ)+856
  • Latvia (Latvija)+371
  • Lebanon (‫لبنان‬‎)+961
  • Lesotho+266
  • Liberia+231
  • Libya (‫ليبيا‬‎)+218
  • Liechtenstein+423
  • Lithuania (Lietuva)+370
  • Luxembourg+352
  • Macau (澳門)+853
  • Macedonia (FYROM) (Македонија)+389
  • Madagascar (Madagasikara)+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania (‫موريتانيا‬‎)+222
  • Mauritius (Moris)+230
  • Mayotte+262
  • Mexico (México)+52
  • Micronesia+691
  • Moldova (Republica Moldova)+373
  • Monaco+377
  • Mongolia (Монгол)+976
  • Montenegro (Crna Gora)+382
  • Montserrat+1664
  • Morocco (‫المغرب‬‎)+212
  • Mozambique (Moçambique)+258
  • Myanmar (Burma) (မြန်မာ)+95
  • Namibia (Namibië)+264
  • Nauru+674
  • Nepal (नेपाल)+977
  • Netherlands (Nederland)+31
  • New Caledonia (Nouvelle-Calédonie)+687
  • New Zealand+64
  • Nicaragua+505
  • Niger (Nijar)+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea (조선 민주주의 인민 공화국)+850
  • Northern Mariana Islands+1670
  • Norway (Norge)+47
  • Oman (‫عُمان‬‎)+968
  • Pakistan (‫پاکستان‬‎)+92
  • Palau+680
  • Palestine (‫فلسطين‬‎)+970
  • Panama (Panamá)+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru (Perú)+51
  • Philippines+63
  • Poland (Polska)+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar (‫قطر‬‎)+974
  • Réunion (La Réunion)+262
  • Romania (România)+40
  • Russia (Россия)+7
  • Rwanda+250
  • Saint Barthélemy+590
  • Saint Helena+290
  • Saint Kitts and Nevis+1869
  • Saint Lucia+1758
  • Saint Martin (Saint-Martin (partie française))+590
  • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
  • Saint Vincent and the Grenadines+1784
  • Samoa+685
  • San Marino+378
  • São Tomé and Príncipe (São Tomé e Príncipe)+239
  • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • Senegal (Sénégal)+221
  • Serbia (Србија)+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1721
  • Slovakia (Slovensko)+421
  • Slovenia (Slovenija)+386
  • Solomon Islands+677
  • Somalia (Soomaaliya)+252
  • South Africa+27
  • South Korea (대한민국)+82
  • South Sudan (‫جنوب السودان‬‎)+211
  • Spain (España)+34
  • Sri Lanka (ශ්‍රී ලංකාව)+94
  • Sudan (‫السودان‬‎)+249
  • Suriname+597
  • Svalbard and Jan Mayen+47
  • Swaziland+268
  • Sweden (Sverige)+46
  • Switzerland (Schweiz)+41
  • Syria (‫سوريا‬‎)+963
  • Taiwan (台灣)+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand (ไทย)+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad and Tobago+1868
  • Tunisia (‫تونس‬‎)+216
  • Turkey (Türkiye)+90
  • Turkmenistan+993
  • Turks and Caicos Islands+1649
  • Tuvalu+688
  • U.S. Virgin Islands+1340
  • Uganda+256
  • Ukraine (Україна)+380
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan (Oʻzbekiston)+998
  • Vanuatu+678
  • Vatican City (Città del Vaticano)+39
  • Venezuela+58
  • Vietnam (Việt Nam)+84
  • Wallis and Futuna (Wallis-et-Futuna)+681
  • Western Sahara (‫الصحراء الغربية‬‎)+212
  • Yemen (‫اليمن‬‎)+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358
Mobile number

Email

Other Products in 'Active Pharmaceuticals Ingredients (API)' category